"saxagliptin" meaning in All languages combined

See saxagliptin on Wiktionary

Noun [English]

IPA: /ˌsæk.səˈɡlɪp.tɪn/ [General-American]
Etymology: From [Term?] + -gliptin (“dipeptidyl aminopeptidase-IV inhibitor”). Etymology templates: {{af|en||-gliptin|t2=dipeptidyl aminopeptidase-IV inhibitor}} [Term?] + -gliptin (“dipeptidyl aminopeptidase-IV inhibitor”) Head templates: {{en-noun|-}} saxagliptin (uncountable)
  1. (pharmacology) A hypoglycemic drug taken orally in the form of its hydrate C₁₈H₂₅N₃O₂·H₂O in the treatment of type 2 diabetes. It acts by inhibiting the degradation of incretins, which results in increased secretion of insulin by the pancreas. It is marketed under the trademark Onglyza and when used in combination with metformin, under the trademark Kombiglyze. Wikipedia link: saxagliptin Tags: uncountable Categories (topical): Pharmaceutical drugs
    Sense id: en-saxagliptin-en-noun-mVY64GxO Categories (other): English entries with incorrect language header, English terms suffixed with -gliptin Topics: medicine, pharmacology, sciences

Download JSON data for saxagliptin meaning in All languages combined (2.3kB)

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "",
        "3": "-gliptin",
        "t2": "dipeptidyl aminopeptidase-IV inhibitor"
      },
      "expansion": "[Term?] + -gliptin (“dipeptidyl aminopeptidase-IV inhibitor”)",
      "name": "af"
    }
  ],
  "etymology_text": "From [Term?] + -gliptin (“dipeptidyl aminopeptidase-IV inhibitor”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "saxagliptin (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms suffixed with -gliptin",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "topical",
          "langcode": "en",
          "name": "Pharmaceutical drugs",
          "orig": "en:Pharmaceutical drugs",
          "parents": [
            "Drugs",
            "Matter",
            "Pharmacology",
            "Chemistry",
            "Nature",
            "Biochemistry",
            "Medicine",
            "Sciences",
            "All topics",
            "Biology",
            "Fundamental"
          ],
          "source": "w"
        }
      ],
      "glosses": [
        "A hypoglycemic drug taken orally in the form of its hydrate C₁₈H₂₅N₃O₂·H₂O in the treatment of type 2 diabetes. It acts by inhibiting the degradation of incretins, which results in increased secretion of insulin by the pancreas. It is marketed under the trademark Onglyza and when used in combination with metformin, under the trademark Kombiglyze."
      ],
      "id": "en-saxagliptin-en-noun-mVY64GxO",
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "hypoglycemic",
          "hypoglycemic"
        ],
        [
          "drug",
          "drug"
        ],
        [
          "orally",
          "orally"
        ],
        [
          "hydrate",
          "hydrate"
        ],
        [
          "degradation",
          "degradation"
        ],
        [
          "incretin",
          "incretin"
        ],
        [
          "insulin",
          "insulin"
        ],
        [
          "pancreas",
          "pancreas"
        ],
        [
          "Onglyza",
          "Onglyza"
        ],
        [
          "metformin",
          "metformin"
        ],
        [
          "Kombiglyze",
          "Kombiglyze"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A hypoglycemic drug taken orally in the form of its hydrate C₁₈H₂₅N₃O₂·H₂O in the treatment of type 2 diabetes. It acts by inhibiting the degradation of incretins, which results in increased secretion of insulin by the pancreas. It is marketed under the trademark Onglyza and when used in combination with metformin, under the trademark Kombiglyze."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "saxagliptin"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/ˌsæk.səˈɡlɪp.tɪn/",
      "tags": [
        "General-American"
      ]
    }
  ],
  "word": "saxagliptin"
}
{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "",
        "3": "-gliptin",
        "t2": "dipeptidyl aminopeptidase-IV inhibitor"
      },
      "expansion": "[Term?] + -gliptin (“dipeptidyl aminopeptidase-IV inhibitor”)",
      "name": "af"
    }
  ],
  "etymology_text": "From [Term?] + -gliptin (“dipeptidyl aminopeptidase-IV inhibitor”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "saxagliptin (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "English 4-syllable words",
        "English entries with incorrect language header",
        "English lemmas",
        "English nouns",
        "English term requests",
        "English terms suffixed with -gliptin",
        "English terms with IPA pronunciation",
        "English uncountable nouns",
        "en:Pharmaceutical drugs"
      ],
      "glosses": [
        "A hypoglycemic drug taken orally in the form of its hydrate C₁₈H₂₅N₃O₂·H₂O in the treatment of type 2 diabetes. It acts by inhibiting the degradation of incretins, which results in increased secretion of insulin by the pancreas. It is marketed under the trademark Onglyza and when used in combination with metformin, under the trademark Kombiglyze."
      ],
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "hypoglycemic",
          "hypoglycemic"
        ],
        [
          "drug",
          "drug"
        ],
        [
          "orally",
          "orally"
        ],
        [
          "hydrate",
          "hydrate"
        ],
        [
          "degradation",
          "degradation"
        ],
        [
          "incretin",
          "incretin"
        ],
        [
          "insulin",
          "insulin"
        ],
        [
          "pancreas",
          "pancreas"
        ],
        [
          "Onglyza",
          "Onglyza"
        ],
        [
          "metformin",
          "metformin"
        ],
        [
          "Kombiglyze",
          "Kombiglyze"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A hypoglycemic drug taken orally in the form of its hydrate C₁₈H₂₅N₃O₂·H₂O in the treatment of type 2 diabetes. It acts by inhibiting the degradation of incretins, which results in increased secretion of insulin by the pancreas. It is marketed under the trademark Onglyza and when used in combination with metformin, under the trademark Kombiglyze."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "saxagliptin"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/ˌsæk.səˈɡlɪp.tɪn/",
      "tags": [
        "General-American"
      ]
    }
  ],
  "word": "saxagliptin"
}

This page is a part of the kaikki.org machine-readable All languages combined dictionary. This dictionary is based on structured data extracted on 2024-05-24 from the enwiktionary dump dated 2024-05-02 using wiktextract (46b31b8 and c7ea76d). The data shown on this site has been post-processed and various details (e.g., extra categories) removed, some information disambiguated, and additional data merged from other sources. See the raw data download page for the unprocessed wiktextract data.

If you use this data in academic research, please cite Tatu Ylonen: Wiktextract: Wiktionary as Machine-Readable Structured Data, Proceedings of the 13th Conference on Language Resources and Evaluation (LREC), pp. 1317-1325, Marseille, 20-25 June 2022. Linking to the relevant page(s) under https://kaikki.org would also be greatly appreciated.